Issue : CP June 2017 online
Sort by: Newest first Oldest first A-Z Z-A
-
Chronic open-angle glaucoma: case study
Understand how to advise on chronic-open angle glaucoma, a condition in which intraocular pressure can permanently damage the optic nerve and nerve fibre, leading to blindness if left untreated.
-
Antiviral treatment improves outcomes in patients with advanced cirrhosis Subscription
Hepatitis C drug shown to reduce the need for transplant and lower mortality rate in patients with advanced liver disease.
-
Effects of ADHD drug on the brain are reversible, study suggests Subscription
Even high doses over an extended treatment period were not detectable in brain regions after a month’s abstinence, according to animal study.
-
Leukaemia drug stems allergen response in exploratory study Subscription
The tyrosine kinase inhibitor ibrutinib can help to block allergic reactions and prevent anaphylaxis, a study finds.
-
‘Liquid biopsy’ guides PARP inhibitor treatment of prostate cancer Subscription
Analysis of circulating free tumour DNA in blood shows how well cancer therapy is working and can inform further treatment.
-
Metformin may have cardiovascular benefits in patients with type 1 diabetes Subscription
Guidelines recommend off-label use of metformin in type 1 diabetes to reduce insulin dosages and improve glycaemic control. However, it is not known whether it has any cardiovascular benefits.
-
Experimental cholesterol drug failed to prevent cardiovascular events Subscription
Phase III trial halted early as treatment did not reduce rate of vascular events in patients with high-risk disease.
-
Penicillin allergy often inaccurately recorded by healthcare professionals Subscription
Researchers find that only one-third of medical records accurately reflected patients’ reported allergic reactions to penicillin.
-
Lack of robust post-approval studies under FDA system Subscription
Review of drugs approved on the basis of limited evidence concludes that stricter rules are needed for post-approval studies.
-
Blood sugar self-monitoring in non-insulin treated type 2 diabetes doesn’t improve control Subscription
It has been debated whether self-monitoring blood glucose levels has any value in improving glycaemic control for patients with type 2 diabetes not requiring insulin.
Show 10 per page20 per page
